Patent ID: 11859168
Assignee: CHRISTOPHER B. REID
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 12:
13. The method of claim 1, wherein the nucleated cell is transfected with a third one or more polypeptide, and/or with ribonucleic acids or deoxyribonucleic acids encoding one or more third polypeptides, wherein the one or more third polypeptide is selected from a short Numb isoform, Numblike, MyoD, myogenin, Myocardin, Ifrd1, Myf 5, Myf 6, Mef2, Gata 4, Gata 5, and Gata 6, Sox9, CREB-binding polypeptide, Runx2, HNF-I, HNF-3, HNF-4, HNF-6, Nurr1, REN, Neurogenin1, Neurogenin2, Neurogenin3, Mash 1, Phox2a, Phox2b, dHand, Gata3, Shh, FGF8, Lmxlb, Nkx2.2, Pet1, Lbx1, Rnx, PITX2, Dlx2, Dlx5, Ngn2, Ptx-3, Gata2, REST4, Foxa2, Sox17, HLXB9, Runx1/AML, Pdxl, OLIG1, OLIG2, NOV(CCN3), and Zfp488, or said nucleic acid comprises antisense Hes1 RNA.